Results: 31 product(s) found
3D Printed IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Levonorgestrel
  • Tenofovir Disoproxil Fumarate (TDF)
  • University of North Carolina, Chapel Hill
  • P1
  • HIV
  • HSV-2
  • Pregnancy
  • Amphora Gel MPT in Development Topical Gel-Vaginal
  • Citric Acid
  • L-lactic Acid
  • Potassium Bitartrate
  • Evofem Inc.
  • C3
  • Chlamydia
  • Gonorrhea
  • Pregnancy
  • BioRings TM IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Ascorbic Acid
  • Boc-Lysinated Betulonic Acid
  • Ferrous Gluconate
  • Polyamino-Polycarboxlic Acid
  • Tenofovir (TFV)
  • BioRings LLC
  • P1
  • HIV
  • Pregnancy
  • Co-formulated oral contraceptive MPT MPT in Development Systemic Pill/Capsule/Tablet- Oral
  • Combined Oral Contraceptive (COC)
  • Emtricitabine (FTC)
  • Tenofovir Disoproxil Fumarate (TDF)
  • Population Council
  • C4
  • HIV
  • Pregnancy
  • Dapivirine + Levonorgestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Dapivirine
  • Levonorgestrel
  • International Partnership for Microbicides (IPM)
  • C1
  • HIV
  • Pregnancy
  • Elvitegravir + Copper IUS MPT in Development Systemic Intrauterine Reservoir Devices
  • Copper
  • Elvitegravir
  • CONRAD
  • P2
  • HIV
  • Pregnancy
  • Etonogestrel + Ethinyl Estradiol + QGriffithsin IVR (EEQ IVR) [PC-8500] MPT in Development Topical Intravaginal Ring (IVR)
  • Etonogestrel
  • Ethinyl Estradiol
  • Population Council
  • P2
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • Griffithsin (GRFT) in Carrageenan gel (PC-6500) MPT in Development Topical Gel-Vaginal
  • Griffithsin (GRFT)
  • Population Council
  • C1
  • HIV
  • HPV
  • HSV-2
  • Griffithsin Gel MPT in Development Topical Gel-Rectal
  • Griffithsin (GRFT)
  • University of Louisville
  • P1
  • Chlamydia
  • HIV
  • HSV-2
  • HCA + VRC01 + N6 IVR MPT in Development Topical Intravaginal Ring (IVR)
  • HCA
  • Monoclonal Antibodies
  • VRC01 + N6
  • MUCOMMUNE LLC
  • P2
  • HIV
  • Pregnancy
  • HER102 MPT in Development Topical Fast Dissolve Insert/Capsule-Vaginal
  • Lactobacillus
  • Other
  • Hervana Bio
  • P1
  • Bacterial Vaginosis (BV)
  • Gonorrhea
  • Pregnancy
  • mAb 2C7 + TDF IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Monoclonal Antibodies
  • Tenofovir Disoproxil Fumarate (TDF)
  • MassBiologics
  • Oak Institute of Science
  • Planet Biotechnology, Inc.
  • University of Massachusetts
  • P1
  • Gonorrhea
  • HIV
  • MB66 Film MPT in Development Topical Film - Vaginal
  • Monoclonal Antibodies
  • Mapp Biopharmaceutical, Inc.
  • C1
  • HIV
  • HSV-2
  • MB66+ Film MPT in Development Topical Film - Vaginal
  • Monoclonal Antibodies
  • Mapp Biopharmaceutical, Inc.
  • ZabBio, Inc.
  • C0
  • HIV
  • HSV-2
  • Pregnancy
  • MIV-150 and zinc acetate in a carrageenan gel (PC-1005) + SILCS (Caya) diaphragm MPT in Development Barrier with Drug Diaphragm
  • Carrageenan
  • MIV-150
  • Zinc Acetate
  • CONRAD
  • Kessel
  • PATH
  • Population Council
  • C2
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • MIV-150 and zinc acetate in carrageenan gel (PC-1005) MPT in Development Topical Gel-Vaginal;Rectal
  • Carrageenan
  • MIV-150
  • Zinc Acetate
  • Population Council
  • C2
  • HIV
  • HPV
  • HSV-2
  • MPT Microarray Patch (MAP) MPT in Development Systemic Microarray Patch
  • Cabotegravir
  • Norelgestromin
  • PATH
  • P1
  • HIV
  • Pregnancy
  • OB-001 MPT in Development Topical Gel-Vaginal
  • Matrine
  • Octoxynol-9
  • Orion Biotechnology
  • P2
  • HIV
  • Pregnancy
  • Over-encapsulated oral contraceptive MPT MPT in Development Systemic Pill/Capsule/Tablet- Oral
  • Combined Oral Contraceptive (COC)
  • Emtricitabine (FTC)
  • Tenofovir Disoproxil Fumarate (TDF)
  • Population Council
  • C4
  • HIV
  • Pregnancy
  • poly-[1,4-phenylene-(1-carboxy) methylene] (PPCM) SAMMA Gel MPT in Development Topical Gel-Vaginal
  • poly-[1,4-phenylene-(1-carboxy) methylene
  • Yaso Therepeutics
  • P2
  • Chlamydia
  • Gonorrhea
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • QGriffithsin (QGRFT)/Carrageenan (CG) fast dissolve insert MPT in Development Topical Fast Dissolve Insert/Capsule-Vaginal
  • Griffithsin (GRFT)
  • PATH
  • Population Council
  • P2
  • HIV
  • HPV
  • HSV-2
  • QGriffithsin/Carrageenan (QC) IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Griffithsin (GRFT)
  • Population Council
  • P1
  • HIV
  • HPV
  • HSV-2
  • SR-2P Gel MPT in Development Topical Gel-Vaginal
  • Acyclovir
  • SR-2P (Bioadhesive Polymer Gel)
  • Tenofovir (TFV)
  • SRI International
  • P1
  • HIV
  • HSV-2
  • Subcutaneous Contraceptive and HIV Implant Engineered for Long-Acting Delivery (SCHIELD) device MPT in Development Systemic Implant (Subcutaneous)
  • Unspecified
  • Research Triangle International (RTI)
  • P1
  • HIV
  • Pregnancy
  • TAF / Elvitegravir Topical Insert MPT in Development Topical Fast Dissolve Insert – Vaginal, Rectal
  • Elvitegravir
  • Tenofovir Alafenamide (TAF)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • TDF + FTC + Acyclovir + Ethinyl Estradiol + Etonogestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Emtricitabine (FTC)
  • Etonogestrel
  • Ethinyl Estradiol
  • Tenofovir Disoproxil Fumarate (TDF)
  • Auritec Pharmaceuticals
  • P2
  • HIV
  • HSV-2
  • Pregnancy
  • Tenofovir / Acyclovir IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Tenofovir (TFV)
  • CONRAD
  • P2
  • HIV
  • HSV-1
  • HSV-2
  • Tenofovir + Levonorgestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Levonorgestrel
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • Pregnancy
  • Tenofovir Disoproxil Fumarate (TDF) IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Tenofovir Disoproxil Fumarate (TDF)
  • Albert Einstein College of Medicine
  • C1
  • HIV
  • HSV-2
  • Tenofovir IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • VivaGel® Vaginal Gel MPT in Development Topical Gel-Vaginal
  • SPL7013 (Astodrimer Sodium)
  • Starpharma Pty Limited
  • P2
  • Bacterial Vaginosis (BV)
  • HIV
  • HSV-2
  • IMPT Secretariat
    1750 Howe Avenue, Suite 550
    Sacramento, CA 95825
    This email address is being protected from spambots. You need JavaScript enabled to view it.

    © Copyright 2019, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated to advancing the comprehensive sexual and reproductive health of women and girls worldwide. CAMI Health is housed at the Public Health Institute (PHI).

    This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.
    PEPFAR USAID PHI CAMI Health